Other
Gene Polymorphism
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Gene Polymorphism is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
14
clinical trials
Completed6 · 43%
Unknown status5 · 36%
Terminated2 · 14%
Recruiting1 · 7%
Clinical Trials
Trial Activity
14 trials
Association Study Between CYP1A2 Gene Polymorphisms and Metabolism of Theophylline
Completed·—·N/A·NCT03015090·110 enrolled
VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
Unknown status·—·N/A·NCT00970892·500 enrolled
Influence of Ethnicity and ABCB1 Gene Polymorphism on the Pharmacokinetics of Azithromycin in Healthy Bangladeshi Volunteers
Unknown status·—·Phase 1·NCT05437783·24 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)